Initiating Conversations to Reduce Harm Across Care Settings: Healthcare Opportunities

Size: px
Start display at page:

Download "Initiating Conversations to Reduce Harm Across Care Settings: Healthcare Opportunities"

Transcription

1 Harm Reduction in an Opioid Era: Initiating Conversations to Reduce Harm Across Care Settings: Healthcare Opportunities Presented by: Kerry Nolte, PhD, FNP-C January 18, 2018

2 Harm Reduction: It s Not Just for SSPs Harm Reduction = Engagement Communicates Caring Discuss 1-2 opportunities to reduce risk Learn more about substance use patterns in your community

3 Source

4 Less About What You Say More About Your Approach

5 Reframing the Starting Point: Engagement in Care Acceptance Provider Humility Curiosity to Learn About SUD Supportive and Pragmatic Conversation

6 Engage in Goal Setting to Reduce Harm Goal: provide support and resources for client s self defined goals PWID are interested and capable of making changes to improve health and safety Safety messages shared could be rapidly spread through a social network Recognize and support readiness to change, whether safer injecting or recovery

7 SBIRT Screening Brief Intervention Referral to Treatment Consider questions about injecting or injury Have you ever used a drug by injecting it? Can you tell me more about this wound because I think we can treat and prevent this? Were you using drugs when this injury occurred because we could talk about ways to prevent another injury?

8 BNI: Brief Negotiated Interview Discussion based on pt report: 0-3: expresses concern, asks if pt wants more info, then offers support and makes f/u plan about future visits (drops it in respect of pt s choice) 4-7, ask Why did you choose and not (a lower number)?, What would need to happen for you to go from (a given number) to a (a higher number)? Stimulates change talk. After reflecting/summarizing, negotiate a plan with pt to cut back or quit; help pt identify resources. 8 or higher, help pt develop action plan. Assist pt with identifying resources to help cut back/quit. Instill hope!!!

9 BNI: Brief Negotiated Interview Referral to Treatment: 0-3: Know I (or agency) am here as a resource if you are interested in support in decreasing or stopping substance use. Could we discuss some things that could help to keep you safe? **HARM REDUCTION MOST IMPORTANT** 4-7: make the referral and ask patient what he or she thinks might happen with it 8 or higher: work with pt to make an appointment with an appropriate treatment provider ( active referral )

10 Harm Reduction: It s Not Just for SSPs Harm Reduction = Engagement Communicates Caring Discuss 1-2 opportunities to reduce risk Learn more about substance use patterns in your community

11 SBIRT Screening Brief Intervention Referral to Treatment Consider questions about injecting or injury Have you ever used a drug by injecting it? Can you tell me more about this wound because I think we can treat and prevent this? Were you using drugs when this injury occurred because we could talk about ways to prevent another injury?

12 BNI: Brief Negotiated Interview Discussion based on pt report: 0-3: interviewer expresses concern, asks if pt wants more info about substance effects on health, then offers support and makes f/u plan about future visits (drops it in respect of pt s choice) 4-7, ask Why did you choose and not (a lower number)?, What would need to happen for you to go from (a given number) to a (a higher number)? Stimulates change talk. After reflecting/summarizing, negotiate a plan with pt to cut back or quit; help pt identify resources. 8 or higher, help pt develop action plan. Assist pt with identifying resources to help cut back/quit. Instill hope!!!

13 BNI: Brief Negotiated Interview Referral to Treatment (for those who screen as dependent use): 0-3: Although referring you to treatment is what I recommend, I understand you are not ready to do this today. If you change your mind please let me know and can I bring it up again at our next visit? **HARM REDUCTION CARE CAN STILL OCCUR ** 4-7: make the referral and ask patient what he or she thinks might happen with it 8 or higher: work with pt to make an appointment with an appropriate treatment provider ( active referral ) Example of Brief Intervention with a Heroin User (Credit Boston Univ. School of Public Health BNI-ART Institute):

14 Safer Supplies Ask: Are you able to get clean supplies (needles, cookers, cottons)? If needles have to be reused, HCV can be reduced and HIV eliminated with bleach. 7 Risk dramatically reduced with rinsing 3 times with water Advise using clean, single use works Cottons, cookers, and clean water (sterile)

15 Safer Use Ask: What steps do you take to keep yourself safe when using? Advise to not use alone and only with trusted people who can provide care if needed Caution with all drug supplies and new sources Avoiding taking all the drug at once and avoid rushing Starting with a test shot may help prevent overdose as drug cannot be taken back once injected. 6 Problem solve around a safer environment and/or opportunities to decrease frequency.

16 Microscope View of Needle After Use

17 Safer Use Ask: Do you have naloxone (Narcan) available in the case of an overdose?

18 Naloxone Administration

19 Safer Use Ask: How do you prevent injury to your veins and infections? Wash hands or use hand sanitizer/ alcohol 8 Tourniquet improves vein access (fewer needle sticks, less risk for infection) 6 Removing tourniquet before injecting Do not inject if bright red blood fills syringe Bevel up to avoid going through the vein Recognize valves in veins and inject above Recognize infections and when to seek care for wound/ illness/ infection Offer the Harm Reduction Coalition s manual Getting Off Right for more tips. 6

20

21 Normal Vein Valves Injured Valves Image source

22 Safer Disposal Ask: Are you able to safely get rid of supplies like syringes and needles? Syringe service programs can dispose of needles Some health, fire departments, and transfer stations provide safe places to dispose of syringes Consider if your care setting can help in safe disposal If unavailable, needles should be placed in a hard plastic bottle (e.g. detergent bottle). Once ¾ full, tape the lid with duct tape, label DO NOT RECYCLE, and place in the regular trash. 6

23

24 Health Promotion Offer Preventative Care: Screening, Testing, and Education HIV testing is recommended at least annually for PWID. Include HIV 1/2 antibody and HIV 1 p24 antigen testing (positive 21 days after infection). 9 Consider discussing PreExposure Prophylaxis (PrEP) for HIV prevention. (CDC, 2017) Hepatitis C antibody testing is recommended periodically for PWID. 10 If exposure may have occurred with 6 months consider HCV RNA testing. 11 Check Tdap, HPV, Hepatitis A and B vaccination status and immunize as needed. 12 Discuss safe sexual practices and provide condoms. 12 Review pregnancy prevention options. 12

25 Refer and Collaborate with SSPs

26

27

28

29 Questions? Contact Info: Kerry Nolte

30 References Bartlett, R., Brown, L., Shattell, M., Wright, T., & Lewallen, L. (2013). Harm reduction: compassionate care of persons with addictions. MedSurg Nursing, (6) Botticelli, M. P., & Koh, H. K. (2016). Changing the Language of Addiction. Jama, 316(13), doi: /jama Case, A., & Deaton, A. (2017). Mortality and morbidity in the 21st century. Brookings Papers On Economic Activity, 397. Centers for Disease Control and Prevention (2016). Reducing harms from injection drug use and opiod use disorder with syringe service programs. Retrieved from Connery, H. S. (2015). Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions. Harvard Review Of Psychiatry (Lippincott Williams & Wilkins), 23(2), doi: /hrp Drew, D.J. and St. Marie, B.J. (2011). Pain in Critically Ill Patients with Substance use Disorder or Long-term Opioid Use for Chronic Pain. AACN Advanced Critical Care. 22(3), pp D'Onofrio, G., O'Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S., Owens, P. H., &... Fiellin, D. A. (2015). Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence. JAMA, The Journal Of The American Medical Association, (16), Foundation for Healthy Communities (2017). Language is powerful. Retrieved fromhttps://healthynh.com/index.php/fhcinitiatives/oud-access-to-treatment.html Katz, J. (Sept 26, 2017) The First Count of Fentanyl Deaths in 2016: Up 540% in Three Years. New York Times. Retrieved at: Kelly, J. F., & Westerhoff, C. M. (2010). Research paper: Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. International Journal Of Drug Policy, doi: /j.drugpo Kelly, J. F., Dow, S. J., & Westerhoff, C. (2010). Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. Journal Of Drug Issues, (4), 805. Kelly, J.F. Saitz, R.and Wakeman, S.(2016) Language, Substance Use Disorders, and Policy: The Need to Reach Consensus on an Addiction-ary, Alcoholism Treatment Quarterly, 34:1, , DOI: /

31 References Harm Reduction Coalition (n.d.) Principles of harm reduction. Retrieved from Noska, A., Mohan, A., Wakeman, S., Rich, J., & Boutwell, A. (2015). Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings. Journal Of Addictive Behaviors, Therapy & Rehabilitation, 4(2) Rollnick, S., Miller, W. R., & Butler, C. (2008). Motivational interviewing in health care: Helping patients change behavior. New York: Guilford Press. Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, Karlsen K.(2011). Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD DOI: / CD pub2. Summers, P. (May 16, 2017), Harm Reduction International Conference presentation. Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter M, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry 2015; 207: 5 14 Svalavitz,M. (2017). The Social Life of Opioids. Scientific American. Retrieved at: White, W. (June 10, 2016). Peer Recovery Coaching: Recent Evidence Reviews. Retrieved at: See conversations handout for additional numbered resources

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017 615 Sheridan Street Port Townsend, WA 98368 www.jeffersoncountypublichealth.org Jefferson County Syringe Exchange Program (SEP) Annual Report Jefferson County Public Health has provided a Syringe Exchange

More information

Screening, Brief Intervention, and Referral to Treatment Core Skills Training

Screening, Brief Intervention, and Referral to Treatment Core Skills Training Screening, Brief Intervention, and Referral to Treatment Core Skills Training Prepared by JBS International, Inc., for the Department of Health lhand Human Services, Substance Abuse and Mental Health Services

More information

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner Testing and prevention of hepatitis C for people who inject drugs Do your patients understand the importance of hepatitis C testing and prevention? Taking an accurate and non-judgmental history of substance

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

CPAA Opioid Response Workgroup Meeting

CPAA Opioid Response Workgroup Meeting CPAA Opioid Response Workgroup Meeting Providence Centralia Hospital June 22 nd, 2017 CASCADE PACIFIC ACTION ALLIANCE 1 Welcome and Introductions Introduce yourself: Name, organization, and county WELCOME

More information

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada Project goals and methods Reduce transmission of HIV and STBBI Improve the quality,

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.

More information

Targeted Outreach & Other Strategies for Increasing HCV Testing

Targeted Outreach & Other Strategies for Increasing HCV Testing Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department

More information

Drug Use, Harm Reduction, and HIP

Drug Use, Harm Reduction, and HIP Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange

More information

Learning Objectives 2/29/2016. Motivational Interviewing in Clinical Trials WHAT IS MOTIVATIONAL INTERVIEWING?

Learning Objectives 2/29/2016. Motivational Interviewing in Clinical Trials WHAT IS MOTIVATIONAL INTERVIEWING? Motivational Interviewing in Clinical Trials Presented by: Steve Martino, PhD & Theresa Moyers, PhD CTN WEB SEMINAR SERIES: A FORUM TO EXCHANGE RESEARCH KNOWLEDGE Produced by: CTN Training This training

More information

Historical Perspectives

Historical Perspectives Why Harm Reduction? 1 Rochelle Head-Dunham, MD FAPA Executive Director and Medical Director Metropolitan Human Services District Clinical Associate Professor of Psychiatry LSU and Tulane Historical Perspectives

More information

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program. This guide is designed to help Community-Based Organizations (CBOs) and other individuals or groups in the planning and implementation of a Mobile Outreach Vehicle (MOV)-based risk-reduction intervention

More information

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access Heather Lusk, MSW hlusk@hhhrc.org Hawaiʻi Health & Harm Reduction Center (H3RC) Reducing harm, promoting health, creating wellness

More information

Talking about SBIRT for adolescents: An upstream intervention to address the heroin and prescription opioid epidemic

Talking about SBIRT for adolescents: An upstream intervention to address the heroin and prescription opioid epidemic Talking about SBIRT for adolescents: An upstream intervention to address the heroin and prescription opioid epidemic Brett R. Harris, DrPH University at Albany School of Public Health Drug Overdose is

More information

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Note: Staff who work in case management programs should attend the AIDS Institute training, Addressing Prevention in HIV Case Management. Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting

More information

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health

More information

Syringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health

Syringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health Syringe Service Programs: Platforms for Engagement September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health Strategy: Syringe Service Programs Harm Reduction focuses

More information

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public

More information

7/31/18. Justin McClenny, LCDC

7/31/18. Justin McClenny, LCDC Justin McClenny, LCDC 1 Training Goals Learn basic Harm Reduction principles, philosophy and techniques to use with their clients and to incorporate into substance use services. Gain an awareness of our

More information

Five Things the Family Physician Needs to Know about Addiction and Harm Reduction

Five Things the Family Physician Needs to Know about Addiction and Harm Reduction Five Things the Family Physician Needs to Know about Addiction and Harm Reduction Dr. Sharon Koivu Palliative Care Physician Consultant, London Health Sciences Centre, Department of Family Medicine, Western

More information

CMBHS Clinical Management of Behavioral Health Services

CMBHS Clinical Management of Behavioral Health Services Client: CMBHS Clinical Management of Behavioral Health Services Case Management AST022 Assessment Information Assessment Number Assessment Date Assessment Type Contact Type Assessment Site Referred By

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result

More information

SYRINGE SERVICES PROGRAMS IN INDIANA

SYRINGE SERVICES PROGRAMS IN INDIANA SYRINGE SERVICES PROGRAMS IN INDIANA Erika L. Chapman, MPH, CPH, CHES, RYT- 200 Harm Reduction Program Manager Division of HIV, STD, Viral Hepatitis Indiana State Department of Health What is Harm Reduction?

More information

Tips For A Safer Injection

Tips For A Safer Injection Tips For A Safer Injection What s Inside... 2 About this booklet HIV Hepatitis B & C Bacterial Infections Be Prepared: Needles Cookers Water Filters Alcohol Swabs Acidifiers Tourniquets Sharps disposal

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV Wayne Crabtree Administrator, Louisville Metro Department of Public Health and Wellness According to the CDC Kentucky

More information

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:

More information

OPIOID WORKGROUP LEADERSHIP TEAM

OPIOID WORKGROUP LEADERSHIP TEAM OPIOID WORKGROUP LEADERSHIP TEAM Community-wide Action Plan and Call to Action This brief summary of the Opioid Action Plan presented to the Skagit County Board of Health on December 13, 2016 provides

More information

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Authors: Despina Tzemis, Lianping Ti, Margot Kuo, Jennifer Campbell, Jane Buxton and the HRSS CommiAee Harm Reduc*on Program

More information

Hepatitis C Best Practice Guidelines For Local Health Departments

Hepatitis C Best Practice Guidelines For Local Health Departments Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have

More information

Take Home Naloxone elearning Module Script

Take Home Naloxone elearning Module Script elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide

More information

QuADS Organisational Standards and Professional Competencies in needle exchange

QuADS Organisational Standards and Professional Competencies in needle exchange QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department

More information

HIV Prevention Service Provider Survey 2014

HIV Prevention Service Provider Survey 2014 Respondent Demographics This survey will help the Florida HIV Prevention Planning Group (PPG) establish the resources and unmet needs of the communities we serve. Please take a few minutes to complete

More information

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Plain-language summary The health needs of people who inject drugs in public places in Glasgow

More information

Syringe Exchange Program Plan

Syringe Exchange Program Plan Syringe Exchange Program Plan Implementation and Evaluation Plan December 2017 403 Burlington St. SE Mandan, ND 58554 p. 701.667.3370 f. 701.667.3371 www.custerhealth.com Table of Contents I. Executive

More information

Advocating for Syringe Exchange Programs

Advocating for Syringe Exchange Programs Advocating for Syringe Exchange Programs AMERICAN BAR ASSOCIATION AIDS COORDINATING COMMITTEE HIV Law & Practice Conference 2018 New Orleans, LA February 22, 2018 William McColl Vice President for Policy

More information

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics

More information

Guidelines For Services Providing Injecting Equipment

Guidelines For Services Providing Injecting Equipment Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014

More information

Introduction to S-BIRT Presented by the Project Fit Team: Melissa Tolstyka MA, LPC Elizabeth Halimi, MSW Debbie Boerma, C-PRC Greg Seedott, MS

Introduction to S-BIRT Presented by the Project Fit Team: Melissa Tolstyka MA, LPC Elizabeth Halimi, MSW Debbie Boerma, C-PRC Greg Seedott, MS Introduction to S-BIRT Presented by the Project Fit Team: Melissa Tolstyka MA, LPC Elizabeth Halimi, MSW Debbie Boerma, C-PRC Greg Seedott, MS Training Objectives To be able to define the need for implementing

More information

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN Harm Reduction at Lummi Tribal Health Center Jessica Rienstra RN The Lummi Tribal Health Center is located in Bellingham, Washington on the Lummi Nation. Established in 1978, LTHC serves close to 6,500

More information

Brief Intervention (BI) for Adolescents

Brief Intervention (BI) for Adolescents Brief Intervention (BI) for Adolescents Sharon Levy, MD, MPH Director, Adolescent Substance Abuse Program Boston Children s Hospital Associate Professor of Pediatrics Harvard Medical School What is BI?

More information

Safeworks and Harm Reduction

Safeworks and Harm Reduction Safeworks and February 5, 2009 1 Safeworks 101 Strategies for Frontline Work Outline 2 is a public health philosophy that reaches people where they are at. It is about reducing the negative consequences

More information

Understanding the Opiate Epidemic

Understanding the Opiate Epidemic Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs

More information

New London CARES Coordinated Access, Resources, Engagement and Support

New London CARES Coordinated Access, Resources, Engagement and Support New London CARES Coordinated Access, Resources, Engagement and Support What are Opioids? Class of drugs that include Heroin Prescription pain relievers oxycodone (OxyContin), hydrocodone (Vicodin), codeine,

More information

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction. Training Objectives By the end of this session you will be able to: 1. Define harm reduction. 2. Recognize key principles of harm reduction. 3. Identify the need for harm reduction, with a PWID focus.

More information

What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen

What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen Harm reduction means a common sense, non-judgmental and pragmatic way of dealing with problems caused by the use of drugs. It

More information

The Emerging Science of E-Cigarette Use and Nicotine Addiction

The Emerging Science of E-Cigarette Use and Nicotine Addiction The Emerging Science of E-Cigarette Use and Nicotine Addiction 2016-2017 TCN Podcast Series Dr. Jay C. Butler, Alaska Department of Health and Social Services and ASTHO President Dr. Brian King, CDC Office

More information

What is injection drug use?

What is injection drug use? What is injection drug use? Essential Standards 7.ATOD.1 Understand the health risks associated with alcohol, tobacco, and other drug use. Clarifying Objectives 7.ATOD.1.2 - Explain health risks resulting

More information

Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop

Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop Joanne DeSanto Iennaco PhD, PMHNP BC, PMHCNS BC, APRN Acknowledgements Yale SBIRT Medical Health

More information

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs James W. Galbraith MD Associate Professor Department of Emergency Medicine UAB Medicine

More information

SAFE Needle Disposal

SAFE Needle Disposal SAFE Needle Disposal What s in this toolkit? A. Reasons for using needles B. Needle use in pictures C. Who can get poked accidentally? D. What are the risks of touching used needles? E. Unsafe ways to

More information

Addiction Epidemiology, Language and Stigma

Addiction Epidemiology, Language and Stigma Addiction Epidemiology, Language and Stigma Laura G. Kehoe, MD, MPH Medical Director, MGH Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Assistant Professor of Medicine, Harvard

More information

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C?

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C? 1 TABLE OF CONTENTS WHAT IS HEPATITIS C? 2 HOW DO PEOPLE GET INFECTED WITH HEPATITIS C? 4 HOW DOES HEPATITIS C AFFECT MY BODY? 6 DOES HEPATITIS C AFFECT PREGNANCY? 8 HOW DO I GET TESTED FOR HEPATITIS C?

More information

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths PREVENTION COLLABORATION IN ACTION Engaging the Right Partners Opportunities for Engaging Partners to Prevent Opioid Overdoserelated Deaths Preventing opioid overdose requires collaboration with a diverse

More information

Coaching Patients If I could choose just one thing

Coaching Patients If I could choose just one thing Coaching Patients If I could choose just one thing Patty Fredericks, MS Essentia Health Heart and Vascular Wellness Program Coaching Patients If I could choose just one thing Patty Fredericks, MS Essentia

More information

Note: The trainings below represent a foundational list, and may be adapted based on audience and need.

Note: The trainings below represent a foundational list, and may be adapted based on audience and need. MOTIVATIONAL INTERVIEWING Introduction to Motivational Interviewing (offered in English and Spanish) 2-day Course (12-14 credit hours) This course is designed to introduce clinicians and staff members

More information

Operational Guideline

Operational Guideline 1 of 6 PURPOSE Prevention of the spread of sexually transmitted and blood-borne infections (STBBI) through distribution of harm reduction supplies SCOPE & GOAL Harm reduction supplies and condoms will

More information

Pharmacy Needle and Syringe Programme. Enhanced Contract

Pharmacy Needle and Syringe Programme. Enhanced Contract Pharmacy Needle and Syringe Programme Enhanced Contract 1 st April 2012 31 st March 2013 Signed on behalf of LPC Signed on behalf of CRI Signed on behalf of Turning Point Signed on behalf of KCA Signed

More information

Harm reduction strategies: Reducing the adverse health consequences of drug abuse

Harm reduction strategies: Reducing the adverse health consequences of drug abuse Harm reduction strategies: Reducing the adverse health consequences of drug abuse 2 ND NATIONAL CONFERENCE ON ALCOHOL AND DRUG ABUSE 10 TH 13 TH JUNE 2013 Moi Sports Centre Kasarani Gymnasium The and Drugs:

More information

Building and enhancing capacity for HCV prevention; BC case scenario

Building and enhancing capacity for HCV prevention; BC case scenario Building and enhancing capacity for HCV prevention; BC case scenario Jane.Buxton@BCCDC.ca Physician epidemiologist hepatitis BCCDC Harm reduction lead 1 Main messages from BC: Good data is important Develop

More information

Responding to the Opioid Epidemic

Responding to the Opioid Epidemic Responding to the Opioid Epidemic Jessica Gray, MD Addiction Medicine Fellow Boston Medical Center ROME New England August 17, 2017 Disclosures for Jessica Gray, MD No conflicts Learning Objectives Describe

More information

Available In person Courses

Available In person Courses Course Catalogue for HIV Education and Training NY www.hivtrainingny.org The NYSDOH AIDS Institute s HIV, STI and Viral Hepatitis Training Programs offer trainings on HIV/AIDS, sexually transmitted infection

More information

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

Informed Consent Flipchart. Version 1.0, 30 Jan 2018 Informed Consent Flipchart Version 1.0, 30 Jan 2018 Knowledge is Power Did you know? Across the world, young women are at high risk of getting HIV. In Africa, more than half of people living with HIV are

More information

COMMUNITY HEALTH DIVISION NEWSLETTER. Then...

COMMUNITY HEALTH DIVISION NEWSLETTER. Then... MOTIVATION TO PREVENT STIS When we STI staff call people who have been diagnosed with a sexually transmitted infection, we want to make sure they and their partners have been treated. We also want to help

More information

Connecticut Adolescent Screening Brief Intervention and Referral to Treatment

Connecticut Adolescent Screening Brief Intervention and Referral to Treatment SK! Connecticut Adolescent Screening Brief Intervention and Referral to Treatment SCREENING TO BRIEF INTERVENTION (S2BI) The following questions ask about your use, if any, of alcohol, tobacco, and other

More information

SECTION IV: IDU Syringe Exchange Data

SECTION IV: IDU Syringe Exchange Data SECTION IV: IDU Syringe Exchange Data 1 IDU/SYRINGE EXCHANGE SURVEY ANALYSIS From the opening of the Needs Assessment process, it was acknowledged that there would be significant challenges in gathering

More information

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by

More information

Identify the benefits of using a Brief Negotiated Intervention (BNI) to screen for alcohol and drug disorders. Review a four step model of Screening,

Identify the benefits of using a Brief Negotiated Intervention (BNI) to screen for alcohol and drug disorders. Review a four step model of Screening, Kate Speck, PhD Identify the benefits of using a Brief Negotiated Intervention (BNI) to screen for alcohol and drug disorders. Review a four step model of Screening, Brief Intervention and Referral to

More information

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers

More information

Needle and syringe distribution

Needle and syringe distribution Needle and syringe distribution facilitate use of a sterile needle and syringe for each injection and reduce transmission of human immunodeficiency virus (HIV), hepatitis C (HCV), hepatitis B (HBV), and

More information

Day Seven: Helping HIV Affected Children and Orphans

Day Seven: Helping HIV Affected Children and Orphans Note: This training material is continually being evaluated and updated to reflect current needs and best practices therefore it should be viewed as work in progress. Any person, organization, or institution

More information

Transmission/Prevention

Transmission/Prevention Transmission/Prevention Section Three Transmission/Prevention Hepatitis C is transmitted by blood-to-blood contact. Any break in the skin may allow HCV to enter the body, even if no blood is visible. The

More information

PRECONCEPTION COUNSELING

PRECONCEPTION COUNSELING PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal

More information

Learning about HIV. A Lesson Plan from Rights, Respect, Responsibility: A K-12 Curriculum

Learning about HIV. A Lesson Plan from Rights, Respect, Responsibility: A K-12 Curriculum Learning about HIV A Lesson Plan from Rights, Respect, Responsibility: A K-12 Curriculum Fostering respect and responsibility through age-appropriate sexuality education. NSES ALIGNMENT: By the end of

More information

Quiz: Motivation for Change: Overcoming Helplessness

Quiz: Motivation for Change: Overcoming Helplessness Quiz: Motivation for Change: Overcoming Helplessness Name (first name only): Date: Learned Helplessness refers to feeling powerless to help yourself now and in the future due to an experience of being

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

Presented by: Carol Strike, PhD, Associate Professor at the Dalla Lana School of Public Health, University of Toronto.

Presented by: Carol Strike, PhD, Associate Professor at the Dalla Lana School of Public Health, University of Toronto. Best Practice Recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: Part 1 Presented by: Carol Strike, PhD, Associate

More information

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017 What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD kpfeifer@chcf.org May 5, 2017 Beth Name and picture changed What we believed then Opioids are safer than alternatives

More information

LET S TALK about How do you let your partners know they have been exposed to HIV?

LET S TALK about How do you let your partners know they have been exposed to HIV? LET S TALK about How do you let your partners know they have been exposed to HIV? LET US HELP YOU. Partner Services will help you inform your partners about their exposure What is Partner Services? Partner

More information

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction Stefan G. Kertesz, MD, MSc Diplomate, American Board of Addiction Medicine Associate Professor, University of

More information

Boston's New Harm Reduction Program for Opioid Users Forges New Ground. July 28, 2016

Boston's New Harm Reduction Program for Opioid Users Forges New Ground. July 28, 2016 Boston's New Harm Reduction Program for Opioid Users Forges New Ground July 28, 2016 WHY THIS ISSUE? SPEAKERS TODAY Boston HCH Program (BHCHP): Jessie Gaeta, MD, Chief Medical Officer Joanne Guarino, Chair,

More information

From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5)

From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5) From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5) Region 5 Fatherhood Initiative October 24, 2017 Today s Presentation Public

More information

Screening Brief Intervention and Referral for Treatment (SBIRT) for Substance Use: A Simple, Effective Method for Intervention

Screening Brief Intervention and Referral for Treatment (SBIRT) for Substance Use: A Simple, Effective Method for Intervention Screening Brief Intervention and Referral for Treatment (SBIRT) for Substance Use: A Simple, Effective Method for Intervention Julie Worley, PhD, FNP, PMHNP Kathy Delaney, PhD, PMHNP, FAAN SBIRT Screening:

More information

Safe Needle Disposal Guide

Safe Needle Disposal Guide Safe Needle Disposal Guide the northern way of caring Safe Needle Disposal Guide Table of Contents Introduction... 1 I use needles regularly. What should I do with them?... 4 What risks are associated

More information

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs)

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs) Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs) Self-Advocacy Educator - Max Barrows Sex Educator - Katherine McLaughlin www.elevatustraining.com Sex Educator

More information

Injecting infections What you need to know

Injecting infections What you need to know Injecting infections What you need to know If you inject, please read this booklet. You have been given this booklet because we want to reduce the number of injecting drug users who get HIV and hepatitis

More information

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction Harm Reduction Dennis Radloff Human Services Program Coordinator Substance Abuse Services Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Working

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

Advocating for Sensible Policies in the Age of HCV Cure

Advocating for Sensible Policies in the Age of HCV Cure Advocating for Sensible Policies in the Age of HCV Cure Webcast 2.6 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department Communicable Disease Control Program Manager Webcast Overview

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

The 2017 Orange Guidelines consideration of supervised heroin prescribing

The 2017 Orange Guidelines consideration of supervised heroin prescribing The 2017 Orange Guidelines consideration of supervised heroin prescribing Dr Brian Kidd MD University of Dundee Chair OG5 medical treatments sub-group 2014-17 Declarations I have received no other payments

More information

OPIOID INITIATIVE SMART GOALS AND OBJECTIVES Four Pillar Approach

OPIOID INITIATIVE SMART GOALS AND OBJECTIVES Four Pillar Approach OPIOID INITIATIVE SMART GOALS AND OBJECTIVES 2016-2019 Four Pillar Approach SMART OBJECTIVES Prevention focuses on practical strategies that prevent drug abuse before it even begins on a community level

More information

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections Framework and Response Models Oregon HIV, Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study

More information

HEPATITIS C. The Facts

HEPATITIS C. The Facts HEPATITIS C The Facts Your liver keeps you healthy in many ways, such as by removing toxins from your blood and transforming nutrients from food into energy. Hepatitis means inflammation of the liver.

More information

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Getting to Zero in California: Integration of HIV Prevention and Surveillance Getting to Zero in California: Integration of HIV Prevention and Surveillance Steve Gibson, MSW and Deanna Sykes, PhD CDPH, Office of AIDS November 27, 2017 Learning Objectives Understand reasons for integrated

More information

Protecting and Promoting Health and Equity

Protecting and Promoting Health and Equity Meeting People Where They re at: Locating SFDPH s Hepatitis C Initiative in a Legacy of Drug User Health Services Protecting and Promoting Health and Equity Presented by: Katie Burk, MPH 1 San Francisco

More information

Motivational Interviewing in Chronic Diseases. Janelle W. Coughlin, Ph.D. Megan Lavery, Psy.D.. April 21, 2017

Motivational Interviewing in Chronic Diseases. Janelle W. Coughlin, Ph.D. Megan Lavery, Psy.D.. April 21, 2017 Motivational Interviewing in Chronic Diseases Janelle W. Coughlin, Ph.D. Megan Lavery, Psy.D.. April 21, 2017 Motivational Interviewing in Chronic Diseases Presenter Names: Janelle W. Coughlin, Ph.D. &

More information